Not Medicare Enrolled

Dr. Gregory Scott, M.D.

Pulmonary Disease · Arlington Heights, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1614 W CENTRAL RD, Arlington Heights, IL 60005
8478181184
In practice since 2005 (20 years)
NPI: 1225012990 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Scott from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scott? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Scott

Dr. Gregory Scott is a pulmonary disease specialist in Arlington Heights, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Scott performed 1,497 Medicare services across 1,053 unique beneficiaries.

Between the years covered by Open Payments, Dr. Scott received a total of $11,593 from 36 pharmaceutical and/or device companies across 715 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Scott is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 27% volume in IL $11,593 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,497
Medicare services
Top 27% in IL for pulmonary disease
1,053
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~75 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
325 $63 $228
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
311 $90 $307
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
240 $95 $326
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
173 $8 $120
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
169 $65 $242
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
165 $136 $633
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
64 $125 $545
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
13 $11 $91
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
13 $45 $315
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
12 $43 $317
Online digital E/M service, established patient, 11-20 min
An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days.
12 $20 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,593
Total received (2018-2024)
Avg $1,656/year across 7 years
Top 18% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
715
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,593 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$753
2023
$2,287
2022
$1,806
2021
$1,729
2020
$1,681
2019
$1,735
2018
$1,602

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$186
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
Mylan Specialty L.P.
$88
Electromed, Inc.
$62
GENZYME CORPORATION
$59
AstraZeneca Pharmaceuticals LP
$40
Takeda Pharmaceuticals U.S.A., Inc.
$38
Baxter Healthcare
$38
Regeneron Healthcare Solutions, Inc.
$36
Philips North America LLC
$34
Tactile Systems Technology Inc
$33
La Jolla Pharmaceutical Company
$26
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,756
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,256
AstraZeneca Pharmaceuticals LP
$1,538
Mylan Specialty L.P.
$677
Genentech USA, Inc.
$445
Grifols USA, LLC
$442
Philips Electronics North America Corporation
$296
Takeda Pharmaceuticals U.S.A., Inc.
$287
Mallinckrodt Hospital Products Inc.
$256
Electromed, Inc.
$233
GENZYME CORPORATION
$164
Regeneron Healthcare Solutions, Inc.
$143
Harmony Biosciences LLC
$130
Janssen Pharmaceuticals, Inc
$122
Baxter Healthcare
$106
Advanced Respiratory, Inc
$104
Sunovion Pharmaceuticals Inc.
$96
Merck Sharp & Dohme Corporation
$72
Vapotherm Inc
$39
Covis Pharma GmBH
$38
Amgen Inc.
$38
Vanda Pharmaceuticals Inc.
$34
CSL Behring
$34
Philips North America LLC
$34
Tactile Systems Technology Inc
$33
Circassia Pharmaceuticals Inc
$28
La Jolla Pharmaceutical Company
$26
JAZZ PHARMACEUTICALS INC.
$25
Nabriva Therapeutics, plc
$22
Inogen, Inc.
$20
Insmed, Inc.
$19
Mayne Pharma Inc.
$18
HARMONY BIOSCIENCES LLC
$17
Lilly USA, LLC
$16
Teva Pharmaceuticals USA, Inc.
$15
ADVANCED RESPIRATORY, INC
$11
Top 3 companies account for 65.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · COMBIVENT RESPIMAT · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Esbriet · FARXIGA · FASENRA · Flexitouch Plus · GIAPREZA · GLASSIA · HETLIOZ · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · InogenOne · Kcentra · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System 205 Acute Care · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · VAPOTHERM · WAKIX · Wakix · Wellcentive Undiv · XARELTO · Xenleta · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Arlington Heights?
Compare pulmonary diseases in the Arlington Heights area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
175
Per 100K population
3.4
County median income
$81,797
Nearest hospital
NORTHWEST COMMUNITY HOSPITAL 1
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Scott is a clinical cardiology specialist, with above-average Medicare volume (top 27% in IL), with low-engagement industry engagement in the top 18% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Scott experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Scott performed 325 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Scott receive payments from pharmaceutical companies?
Yes. Dr. Scott received a total of $11,593 from 36 companies across 715 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Scott's costs compare to other pulmonary diseases in Arlington Heights?
Dr. Scott's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Scott) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →